Perioperative Coagulation Management in Cardiac Surgery. (ROTEM)
Primary Purpose
Cardiac Surgery, Bleeding
Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Rotation thromboelastometry (ROTEM)
Standard coagulation managment procedure
Sponsored by

About this trial
This is an interventional health services research trial for Cardiac Surgery focused on measuring Coagulation Management, Cardiac surgery, Bleeding, Rotem
Eligibility Criteria
Inclusion Criteria:
- Adults> 18 years
- Cardiac surgery or heart transplantation with abnormal bleeding regardless the etiology
- given informed consent
Exclusion Criteria:
- Patient supported by a pre or postoperative circulatory technical assistance
Sites / Locations
- Hôpital Haut Levêque- Service d'Anesthésie réanimation Chirurgicale
- Service d'Anesthésie réanimation Chirurgicale
- Service Anésthésie
- Service d'Anesthésie
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Rotem
S
Arm Description
ROTEM: Rotation thromboelastometry
Standard coagulation managment procedure
Outcomes
Primary Outcome Measures
Quantity of different blood transfusion
Secondary Outcome Measures
Full Information
NCT ID
NCT00772239
First Posted
October 13, 2008
Last Updated
April 23, 2011
Sponsor
University Hospital, Limoges
Collaborators
Laboratoire français de Fractionnement et de Biotechnologies
1. Study Identification
Unique Protocol Identification Number
NCT00772239
Brief Title
Perioperative Coagulation Management in Cardiac Surgery.
Acronym
ROTEM
Official Title
Perioperative Coagulation Management in Cardiac Surgery. Rotem Versus Standard Pratctice. A Randomized Trial.
Study Type
Interventional
2. Study Status
Record Verification Date
April 2011
Overall Recruitment Status
Terminated
Study Start Date
October 2008 (undefined)
Primary Completion Date
August 2010 (Actual)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
University Hospital, Limoges
Collaborators
Laboratoire français de Fractionnement et de Biotechnologies
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Cardiac surgery is bleeding requiring transfusion surgery .
The haemorrhagic is related to the need to use high doses of anticoagulants to prevent thrombosis of blood . Moreover, this type of surgery is platelets and coagulation factors consumming despite conducting a thorough anticoagulation.
All these changes contribute to increase the need for transfusions during heart surgery.
The main objective of this study is to compare the need for transfusions in patients suffering from bleeding complications after cardiac surgery with a therapeutic algorithm based on the use of ROTEM ® versus standard tests based solely on standard laboratory tests.
100 pateinst (50 in each arm) should be included in this trial.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiac Surgery, Bleeding
Keywords
Coagulation Management, Cardiac surgery, Bleeding, Rotem
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Rotem
Arm Type
Experimental
Arm Description
ROTEM: Rotation thromboelastometry
Arm Title
S
Arm Type
Active Comparator
Arm Description
Standard coagulation managment procedure
Intervention Type
Device
Intervention Name(s)
Rotation thromboelastometry (ROTEM)
Intervention Description
Coagulation measurement
Intervention Type
Procedure
Intervention Name(s)
Standard coagulation managment procedure
Intervention Description
Standard coagulation managment procedure
Primary Outcome Measure Information:
Title
Quantity of different blood transfusion
Time Frame
during cardiac surgery management
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adults> 18 years
Cardiac surgery or heart transplantation with abnormal bleeding regardless the etiology
given informed consent
Exclusion Criteria:
Patient supported by a pre or postoperative circulatory technical assistance
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nathalie NATHAN-DENIZOT, MD
Organizational Affiliation
CHU limoges
Official's Role
Study Chair
Facility Information:
Facility Name
Hôpital Haut Levêque- Service d'Anesthésie réanimation Chirurgicale
City
Bordeaux
ZIP/Postal Code
33000
Country
France
Facility Name
Service d'Anesthésie réanimation Chirurgicale
City
Bordeaux
ZIP/Postal Code
33000
Country
France
Facility Name
Service Anésthésie
City
Limoges
ZIP/Postal Code
87000
Country
France
Facility Name
Service d'Anesthésie
City
Limoges
ZIP/Postal Code
87000
Country
France
12. IPD Sharing Statement
Learn more about this trial
Perioperative Coagulation Management in Cardiac Surgery.
We'll reach out to this number within 24 hrs